Form EFFECT Evogene Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 29, 2026 |
| Accession Number: | 0001178913-26-004632 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nasdaq grants Evogene a second 180-day window to meet $1 bid rule
- National Real Estate Advisors Promotes Ben Kanne to Managing Director, Investments
- Centauri Direct Earns MEDITECH Alliance Innovator Status
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
